Skip to main content

Nanosonics

Nanosonics Ltd is an Australian multinational infection prevention and medical technology enterprise specializing in the research, development, manufacture, and global wholesale distribution of automated ultrasound probe reprocessing and disinfection systems, high-level disinfection technology (prominently featuring the flagship Trophon device), and specialized infection control consumables utilized in hospitals, radiology departments, and clinical healthcare facilities across Australia, North America, Europe, and international markets. Operating advanced medical device manufacturing facilities in Sydney, Australia, the company is a pioneer in infection prevention innovation. Its core business operations encompass medical device manufacturing, infection control technology engineering, consumables production, and international wholesale distribution. Revenue is derived primarily from the sale and lease of Trophon disinfection devices, recurring service maintenance agreements, and sales of specialized chemical disinfection consumables. Nanosonics holds a leading global market position in ultrasound probe disinfection technology and infection prevention solutions. The company is headquartered in Sydney, New South Wales, Australia, and its ordinary shares trade on the Australian Securities Exchange under the ticker NAN.

2 of the funds FundTelligence covers report a position in Nanosonics.

Legal name
Nanosonics Ltd
Sector
Health Care
Country
Australia
Funds holding it
2

Funds holding Nanosonics

Loading...